Therefore, this study aimed to determine if our swine model of sepsis-induced coagulopathy replicates the increment of a distinct plasma vimentin and to assess the capacity of anti-vimentin on reducing fibrin formation ex vivo in the swine plasma. This evidence concerns the gene VIM and blood coagulation disease.